Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs
Top Cited Papers
- 30 June 2009
- journal article
- Published by Informa UK Limited in Inhalation Toxicology
- Vol. 21 (sup1), 55-60
- https://doi.org/10.1080/08958370902942517
Abstract
Currently, translocation of inhaled insoluble nanoparticles (NP) across membranes like the air-blood barrier into secondary target organs (STOs) is debated. Of key interest are the involved biological mechanisms and NP parameters that determine the efficiency of translocation. We performed NP inhalation studies with rats to derive quantitative biodistribution data on the translocation of NP from lungs to blood circulation and STOs. The inhaled NP were chain aggregates (and agglomerates) of either iridium or carbon, with primary particle sizes of 2-4 nm (Ir) and 5-10 nm (C) and aggregate sizes (mean mobility diameters) between 20 and 80 nm. The carbon aggregates contained a small fraction ( < 1%) of Ir primary particles. The insoluble aggregates were radiolabeled with (192)Ir. During 1 h of inhalation, rats were intubated and ventilated to avoid extrathoracic NP deposition and to optimize deep lung NP deposition. After 24 h, (192)Ir fractions in the range between 0.001 and 0.01 were found in liver, spleen, kidneys, heart, and brain, and an even higher fraction (between 0.01 and 0.05) in the remaining carcass consisting of soft tissue and bone. The fractions of (192)Ir carried with the carbon NP retained in STOs, the skeleton, and soft tissue were significantly lower than with NP made from pure Ir. Furthermore, there was significantly less translocation and accumulation with 80-nm than with 20-nm NP aggregates of Ir. These studies show that both NP characteristics--the material and the size of the chain-type aggregates--determine translocation and accumulation in STOs, skeleton, and soft tissue.Keywords
This publication has 16 references indexed in Scilit:
- Safe handling of nanotechnologyNature, 2006
- Health implications of nanoparticlesJournal of Nanoparticle Research, 2006
- Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategyParticle and Fibre Toxicology, 2005
- Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine ParticlesEnvironmental Health Perspectives, 2005
- NanotoxicologyOccupational and Environmental Medicine, 2004
- Toxicological Hazards of Inhaled Nanoparticles—Potential Implications for Drug DeliveryJournal of Nanoscience and Nanotechnology, 2004
- Diverging long-term trends in ambient urban particle mass and number concentrations associated with emission changes caused by the German unificationAtmospheric Environment, 2003
- TRANSLOCATION OF ULTRAFINE INSOLUBLE IRIDIUM PARTICLES FROM LUNG EPITHELIUM TO EXTRAPULMONARY ORGANS IS SIZE DEPENDENT BUT VERY LOWJournal of Toxicology and Environmental Health, Part A, 2002
- Ultrafine Particles Affect Experimental Thrombosis in an In Vivo Hamster ModelAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Engines and nanoparticlesJournal of Aerosol Science, 1998